BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 16310113)

  • 1. Biodistribution and pharmacokinetics of the (19)F-labeled radiosensitizer 3-aminobenzamide: assessment by (19)F MR imaging.
    Brix G; Schlicker A; Mier W; Peschke P; Bellemann ME
    Magn Reson Imaging; 2005 Nov; 23(9):967-76. PubMed ID: 16310113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo 19F MR imaging and spectroscopy for the BNCT optimization.
    Porcari P; Capuani S; D'Amore E; Lecce M; La Bella A; Fasano F; Migneco LM; Campanella R; Maraviglia B; Pastore FS
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S365-8. PubMed ID: 19375924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic resonance spectroscopy for measuring the biodistribution and in situ in vivo pharmacokinetics of fluorinated compounds: validation using an investigation of liver and heart disposition of tecastemizole.
    Schneider E; Bolo NR; Frederick B; Wilkinson S; Hirashima F; Nassar L; Lyoo IK; Koch P; Jones S; Hwang J; Sung Y; Villafuerte RA; Maier G; Hsu R; Hashoian R; Renshaw PF
    J Clin Pharm Ther; 2006 Jun; 31(3):261-73. PubMed ID: 16789992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Automated detection of prostatic adenocarcinoma from high-resolution ex vivo MRI.
    Madabhushi A; Feldman MD; Metaxas DN; Tomaszeweski J; Chute D
    IEEE Trans Med Imaging; 2005 Dec; 24(12):1611-25. PubMed ID: 16350920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorine-18 click radiosynthesis and preclinical evaluation of a new 18F-labeled folic acid derivative.
    Ross TL; Honer M; Lam PY; Mindt TL; Groehn V; Schibli R; Schubiger PA; Ametamey SM
    Bioconjug Chem; 2008 Dec; 19(12):2462-70. PubMed ID: 19053298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo 19F magnetic resonance spectroscopy and chemical shift imaging of tri-fluoro-nitroimidazole as a potential hypoxia reporter in solid tumors.
    Procissi D; Claus F; Burgman P; Koziorowski J; Chapman JD; Thakur SB; Matei C; Ling CC; Koutcher JA
    Clin Cancer Res; 2007 Jun; 13(12):3738-47. PubMed ID: 17575240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 19F Magnetic resonance imaging of perfluorooctanoic acid encapsulated in liposome for biodistribution measurement.
    Kimura A; Narazaki M; Kanazawa Y; Fujiwara H
    Magn Reson Imaging; 2004 Jul; 22(6):855-60. PubMed ID: 15234455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.
    Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. L-type amino acid transporters LAT1 and LAT4 in cancer: uptake of 3-O-methyl-6-18F-fluoro-L-dopa in human adenocarcinoma and squamous cell carcinoma in vitro and in vivo.
    Haase C; Bergmann R; Fuechtner F; Hoepping A; Pietzsch J
    J Nucl Med; 2007 Dec; 48(12):2063-71. PubMed ID: 18056335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of animal handling on the results of 18F-FDG PET studies in mice.
    Fueger BJ; Czernin J; Hildebrandt I; Tran C; Halpern BS; Stout D; Phelps ME; Weber WA
    J Nucl Med; 2006 Jun; 47(6):999-1006. PubMed ID: 16741310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Folate-poly-L-lysine-Gd-DTPA as MR contrast agent for tumor imaging via folate receptor-targeted delivery].
    Yuan Z; Liu SY; Xiao XS; Zhong GR; Jiang QJ
    Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(10):673-8. PubMed ID: 17553304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and the bystander effect in CD::UPRT/5-FC bi-gene therapy of glioma.
    Shi DZ; Hu WX; Li LX; Chen G; Wei D; Gu PY
    Chin Med J (Engl); 2009 Jun; 122(11):1267-72. PubMed ID: 19567135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MR characterization of mild hyperthermia-induced gadodiamide release from thermosensitive liposomes in solid tumors.
    Peller M; Schwerdt A; Hossann M; Reinl HM; Wang T; Sourbron S; Ogris M; Lindner LH
    Invest Radiol; 2008 Dec; 43(12):877-92. PubMed ID: 19002060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of (19)F-labeled biopharmaceuticals in cell cultures with magnetic resonance.
    Bartusik D; Tomanek B
    Adv Drug Deliv Rev; 2013 Jul; 65(8):1056-64. PubMed ID: 23603212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnetic resonance imaging of mesenchymal stem cells labeled with dual (MR and fluorescence) agents in rat spinal cord injury.
    Shen J; Zhong XM; Duan XH; Cheng LN; Hong GB; Bi XB; Liu Y
    Acad Radiol; 2009 Sep; 16(9):1142-54. PubMed ID: 19660710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of MR image distortion for radiotherapy treatment planning of prostate cancer.
    Chen Z; Ma CM; Paskalev K; Li J; Yang J; Richardson T; Palacio L; Xu X; Chen L
    Phys Med Biol; 2006 Mar; 51(6):1393-403. PubMed ID: 16510951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement of biodistribution and therapeutic index via increase of polyethylene glycol on drug-carrying liposomes in an HT-29/luc xenografted mouse model.
    Chow TH; Lin YY; Hwang JJ; Wang HE; Tseng YL; Wang SJ; Liu RS; Lin WJ; Yang CS; Ting G
    Anticancer Res; 2009 Jun; 29(6):2111-20. PubMed ID: 19528471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gadocoletic acid trisodium salt (b22956/1): a new blood pool magnetic resonance contrast agent with application in coronary angiography.
    de Haën C; Anelli PL; Lorusso V; Morisetti A; Maggioni F; Zheng J; Uggeri F; Cavagna FM
    Invest Radiol; 2006 Mar; 41(3):279-91. PubMed ID: 16481911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the biodistribution and tumor targeting of two 99mTc-labeled anti-EGFR nanobodies in mice, using pinhole SPECT/micro-CT.
    Gainkam LO; Huang L; Caveliers V; Keyaerts M; Hernot S; Vaneycken I; Vanhove C; Revets H; De Baetselier P; Lahoutte T
    J Nucl Med; 2008 May; 49(5):788-95. PubMed ID: 18413403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate and lymph node proton magnetic resonance (MR) spectroscopic imaging with external array coils at 3 T to detect recurrent prostate cancer after radiation therapy.
    Heijmink SW; Scheenen TW; Fütterer JJ; Klomp DW; Heesakkers RA; Hulsbergen-van de Kaa CA; van Lin EN; Heerschap A; Barentsz JO
    Invest Radiol; 2007 Jun; 42(6):420-7. PubMed ID: 17507814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.